Researcher
Ghesquiere Bart
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology, (Bio)molecular modelling and design, Analytical biochemistry, Auto-ecology, Biogeography and phylogeography, Anthropological genetics, Bacteriology, Cell death and senescence, Epigenomics, Environmental safety and health of nanotechnology, Medical biophysics, General diagnostics, Adaptive immunology, Behavioural neuroscience
- Disciplines (KU Leuven):Metabolomics, Separation techniques, Spectrometry, Regulation of metabolism
- See also: Bart Ghesquière (KU Leuven)
Affiliations
- Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Responsible
From1 Oct 2016 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Sep 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Sep 2017 → Today - Ghesquière Lab (Research group)
Responsible
From1 Sep 2017 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Jan 2017 → Today - Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Member
From1 Oct 2016 → 30 Sep 2022 - Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → 30 Sep 2014
Projects
1 - 5 of 5
- Tracer Raman-Driven Mass Spectrometry Imaging (TRaMaSI): a new platform for on-tissue Tracing of Nutritional and Biochemical Trajectories.From1 May 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- VIB Grant for Ghesquière Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- BE19-COMMUNITYLED (Bestaat uit de projecten GALAXY en PLANTS en gedeelte voor BaGh)From1 Jun 2019 → 31 May 2021Funding: EMBL
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’From1 Jan 2018 → 31 Dec 2022Funding: Other EU initiatives out of framework
- VIB Grant for Ghesquière Lab_Period:2018-01-01-2021-12-31From1 Jan 2018 → 31 Dec 2021Funding: FRI - Project driven research
Publications
41 - 50 of 75
- Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase.(2020)
Authors: Bart Ghesquière
Pages: 698 - ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress.(2020)
Authors: Bart Ghesquière, Patrizia Agostinis
Pages: 31198-31207 - ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer.(2020)
Authors: Bart Ghesquière
Pages: 163-178 - Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.(2020)
Authors: Bart Ghesquière
Pages: 274-289 - ATP13A2 deficiency disrupts lysosomal polyamine export.(2020)
Authors: Jean-Paul Decuypere, Willem Annaert, Patrizia Agostinis, Bart Ghesquière
Pages: 419-424 - Metabolites released from apoptotic cells act as tissue messengers.(2020)
Authors: Parul Mehrotra, Bart Ghesquière, Kodimangalam Ravichandran
Pages: 130-135 - Macrophage-derived glutamine boosts satellite cells and muscle regeneration.(2020)
Authors: Min Shang, Federica Cappellesso, Ricardo Amorim, Federico Virga, Guy Eelen, Bart Ghesquière, Peter Carmeliet, Mario di Matteo, Emanuele Berardi, Massimiliano Mazzone
Pages: 626-631 - Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.(2019)
Authors: Tijs Vandoorne, Koen Veys, Wenting Guo, Ann Swijsen, Matthieu Moisse, Guy Eelen, Laura Fumagalli, Raheem Fazal, Sarah-Maria Fendt, Peter Carmeliet, et al.
Pages: 4147 - IL4Ra Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses In Vivo.(2019)
Authors: Peter Carmeliet, Bart Ghesquière
Pages: 235-246 - Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity.(2019)
Authors: Bart Ghesquière, Sarah-Maria Fendt
Pages: 1872-1883
Patents
1 - 5 of 5
- METHODS FOR ANALYZING THE PERFUSATE OF AN EX SITU MACHINE PERFUSED KIDNEY (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)
- Methods and Materials for Treating Glycosylation Disorders (Inventor)